We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A blue beetle.

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

Protein structures.

Scientists Uncover the Cellular Functions of Proteins Integral to Inflammatory Diseases

Two hands holding up a nasal spray, a packet of white pills and a tissue.

Common Antibiotic Shows Promise in the Treatment of Respiratory Viral Infections

Rice Bran Nanoparticles Show Promise as Anti-Cancer Agent

Study Investigates How Aspirin Helps To Prevent Colorectal Cancer Development

Fibrin Immunotherapy’s Potential for Treating Traumatic Brain Injury

News

ACE BioSciences Begins Landmark Phase IIb Proof of Concept Study with its Travellers’ Diarrhoea Vaccine

ACE has begun a Phase IIb study with ACE393, which is said to be the world’s first commercial Campylobacter TD vaccine.

Experimental TB Drug Explodes Bacteria from the Inside Out

Research discovers how an experimental drug unleashes its destructive force inside the bacteria that cause tuberculosis.

Compugen and Merck Serono to Collaborate on Novel Peptide for the Treatment of Inflammatory Diseases

The agreement provides Merck Serono with an option to exclusively license CGEN 855 peptide for worldwide development and commercialization.

Overweight Women at Increased Risk of Advanced Breast Cancer

A study of over 280,000 women showed that postmenopausal obese women have advanced breast cancer at significantly higher rates than women of normal weight.

GENEART Receives Major Contract from the Wellcome Trust Sanger Institute

The Wellcome Trust awards a major contract on synthesizing up to 600 genes over the next 10 months to GENEART.

MorphoSys and Galapagos Enter Alliance to Co-develop Therapeutic Antibodies in Bone and Joint Disease

The alliance combines proprietary drug targets and technologies to create range of new therapeutic antibodies.

Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication

Cephalon obtains an exclusive, worldwide license to the investigational medication Lupuzor™ for the treatment of Systemic Lupus Erythematosus.

Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals

Roche to acquire all the outstanding shares of Memory Pharmaceuticals for approximately USD 50 million.

UT Southwestern Researchers Find Clue to Safer Obesity Drugs

Scientists are trying to understand how a miracle weight-loss drug behaves in the brain in order to develop safer anti-obesity drugs with fewer side effects.

A new Approach to Functional Screening of siRNA Knockdown

Guava Technologies describes an experimental methodology and the new Guava® Software which exploits the advantages of plate based flow technology.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter